Managed health care company Magellan Health, Inc., a subsidiary of Centene (NYSE:CNC), announced on Thursday that it has introduced a Teen Mental Wellbeing app aimed at supporting individuals aged 13-22.
Powered by BeMe Health's digital platform, the app offers evidence-based tools to enhance self-awareness, resilience and mental health.
Designed for use on mobile devices, it provides real-time content tailored to users' moods, skill-building activities and personalized coaching via chat. Clinically validated screenings, including for depression and anxiety, help triage participants to appropriate interventions.
Users have 24/7 access to crisis support and can be referred to virtual therapy sessions through Magellan's employee assistance program.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia